Email Updates

You are here

Home

9 OCTOBER 2020 VOLUME 22 ISSUE 39

Media Coverage

  • PrEP: How To Get HIV Prevention Drug From Superdrug’s New Service

    PrEP is a “game-changing” HIV prevention drug which, after a six-month delay due to the pandemic, is finally being rolled out in England. And now Superdrug, has announced it will be offering the drug as part of their Online Doctor service, making them the first high street store in the UK to provide the drug.

    October 9, 2020
    PrEP
    Forbes

  • Resume PrEP, Urge Community Leaders

    A recently published study by the Kirby Institute at UNSW Sydney found that since late March 2020 there was a steep 41.6 percent fall in HIV pre-exposure prophylaxis (PrEP) use among Australian gay and bisexual men. This was around the time that the first wave of Coronavirus infections hit Australian shores and the country introduced

    October 9, 2020
    PrEP
    Star Observer

  • HPV Vaccine Greatly Lowers Risk of Invasive Cervical Cancer

    The quadrivalent human papillomavirus (HPV) vaccine dramatically reduced the risk of cervical cancer in young women between ages 10 and 30, according to a study conducted in Sweden. The findings were published in The New England Journal of Medicine.

    October 9, 2020
    HPV Vaccines
    POZ

  • Should Men Who Buy Sex Be Considered a Key Population?

    The first comprehensive evidence review of its kind has found men who buy sex are twice as likely to get HIV than other men. It has also found HIV prevalence is consistently higher among men who buy sex than men in the general population.

    October 7, 2020
    Male and Female Condoms, General
    Avert

  • Injectable HIV Therapy Should Save Money if Adherence Is Better Than to Oral Therapies

    A presentation at this week's virtual HIV Glasgow conference on the cost-effectiveness of the new injectable formulation of the antiretroviral drugs cabotegravir and rilpivirine finds that, if it improves adherence relative to oral drugs, it should save the UK NHS money, at least over a patient's lifetime. It would also add from 2-15 weeks to the time people with HIV who take it can expect to live in good health, and would avert some HIV transmissions.

    October 7, 2020
    Treatment
    aidsmap

  • Zimbabweans Take on Global HIV Challenge

    Nowadays people living with HIV can live normal lives without looking or feeling sick, says Miss Yvette Mujeyi of Marondera, Mashonaland East, who has been openly living with the global pandemic for the past 22 years. She is part of the thousands who recently took to Twitter and openly shared with the world how they have been living with one of the world’s most dreaded diseases.

    October 7, 2020
    General
    The Chronicle

  • HIV/AIDS Prevention: NGOs Urge FG to Leverage Pop Culture to Reach Youths

    A coalition of NGOS on Monday urged the Federal Government to utilise diverse popular culture (pop culture) as avenues to create awareness and sensitise youths on HIV/AIDS prevention. The NGOs made the call during an online discussion on the role of media in HIV prevention advocacy’’, organised by the AVAC in collaboration with Journalists Against AIDS Nigeria (JAAIDS).

    October 6, 2020
    PrEP
    The Guardian Nigeria

  • Two-Thirds of People Living With HIV Would Like to Try Injectable Treatment, According to European Survey

    Two-thirds of people on HIV treatment would like to switch to a long-acting injectable regimen, according to a four-country survey presented to the virtual HIV Glasgow conference this week. Healthcare professionals answering the same survey thought fewer people – a quarter – would end up switching.

    October 5, 2020
    Treatment
    aidsmap

Published Research

Announcements